IP Verse

Stable Formulations Of Antibodies To Human Programmed Death Receptor Pd 1 And Related Treatments - EP2691112

PATENT ANALYSIS

Patent Details

Grant Date
May 23, 2018
Company
MERCK SHARP & DOHME CORP.
Oppositions

KONIG SZYNKA TILMANN VON RENESSE

STRAWMAN LIMITED

More patents of Merck Sharp & Dohme Corp.

EP3283882

EP1841493

EP3265122

Want to monitor this patent?

Feel free to send us a message here and we will get back to you